Back to Vanguard Group Inc. Vanguard Group Inc.

ANVSANVS
6 quarters

Position history for Vanguard Group Inc.Vanguard Group Inc.'s holdings in Annovis Bio, Inc.

As of its last 13F, for Q4 2025, Vanguard Group held 923,201 shares of ANVS (Annovis Bio), worth $3.2M. It increased the position by 185,198 shares (+25.1%) from Q3 2025. Vanguard Group held ANVS from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$3.2M

Current Shares

923,201

Total Value Change

+$129,420

Total Shares Change

+542,946

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
923,201
+25.1%
$3.2M0.0%$3.46
22
2025-Q3
Increased
738,003
+5.9%
$1.5M0.0%$2.04
18
2025-Q2
Increased
696,764
+7.5%
$1.5M0.0%$2.05
19
2025-Q1
Increased
647,920
+39.0%
$971,8810.0%$1.65
22
2024-Q4
Increased
466,277
+22.6%
$2.3M0.0%$5.08
21
2024-Q3
First report
380,255
-
$3.1M0.0%$8.10
0

Other major holders of ANVS: Voloridge Investment Management, LLC, Adage Capital Partners GP, L.L.C., Marshall Wace, LLP, Geode Capital Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used